From LncRNAWiki
Jump to: navigation, search

Annotated Information


MIR2052HG:MIR2052 host gene


MIR2052HG(other names:FLJ39080, LOC441355) is a LncRNA gene located on chromosome 8q21.11.[1]


The Knockdown of MIR2052HG[1].

MIR2052HG affects ESR1 and ERα expression and proliferation, colony formation, and response to AIs in ERα-positive breast cancer cell lines.[1]


Functional genomic studies in lymphoblastoid cell lines and ERα-positive breast cancer cell lines shows that expression from MIR2052HG and the ESR1 gene encoding estrogen receptor-α(ERα) is induced by estrogen and AI(aromatase inhibitors) in a SNP-dependent manner. [1]


MIR2052HG is expressed in multiple breast cancer cell lines, including ERα-positive cell lines, according to the Cancer Genomics Hub.[1]


Breast Cancer[1]

Labs working on this lncRNA

  • Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.


  1. 1.0 1.1 1.2 1.3 1.4 1.5 James N. Ingle, Fang Xie, Matthew J. Ellis, Paul E. Goss, Lois E. Shepherd, Judith-Anne W. Chapman, Bingshu E. Chen, Michiaki Kubo, Yoichi Furukawa, Yukihide Momozawa, Vered Stearns, Kathleen I. Pritchard, Poulami Barman, Erin E. Carlson, Matthew P. Goetz, Richard M. Weinshilboum, Krishna R. Kalari and Liewei Wang. Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy. Cancer Res December 1 2016(76)(23) 7012-7023